GR75462B - - Google Patents

Info

Publication number
GR75462B
GR75462B GR67821A GR820167821A GR75462B GR 75462 B GR75462 B GR 75462B GR 67821 A GR67821 A GR 67821A GR 820167821 A GR820167821 A GR 820167821A GR 75462 B GR75462 B GR 75462B
Authority
GR
Greece
Application number
GR67821A
Other languages
Greek (el)
Inventor
J Dr Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR75462B publication Critical patent/GR75462B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR67821A 1981-04-06 1982-04-05 GR75462B (enrdf_load_html_response)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
GR75462B true GR75462B (enrdf_load_html_response) 1984-07-20

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
GR67821A GR75462B (enrdf_load_html_response) 1981-04-06 1982-04-05

Country Status (16)

Country Link
AU (1) AU564570B2 (enrdf_load_html_response)
CA (1) CA1192496A (enrdf_load_html_response)
DE (1) DE3212053A1 (enrdf_load_html_response)
DK (1) DK155882A (enrdf_load_html_response)
ES (1) ES8308698A1 (enrdf_load_html_response)
FI (1) FI821123A7 (enrdf_load_html_response)
FR (1) FR2502951B1 (enrdf_load_html_response)
GB (2) GB2098865B (enrdf_load_html_response)
GR (1) GR75462B (enrdf_load_html_response)
IL (1) IL65424A0 (enrdf_load_html_response)
IT (1) IT8220611A0 (enrdf_load_html_response)
MY (1) MY8600571A (enrdf_load_html_response)
NL (1) NL8201413A (enrdf_load_html_response)
NZ (1) NZ200232A (enrdf_load_html_response)
PT (1) PT74703B (enrdf_load_html_response)
SE (1) SE8202172L (enrdf_load_html_response)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (enrdf_load_html_response) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
WO1985003878A1 (en) * 1984-03-01 1985-09-12 Sandoz Ag Pharmaceutical compositions
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
AU3326493A (en) * 1991-12-16 1993-07-19 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
DK0642332T3 (da) 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp COMPOSITIONS FOR PHARMACEUTICAL EMULSIONS.
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
IN188719B (enrdf_load_html_response) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
WO2000033862A1 (en) * 1998-12-11 2000-06-15 Pharmasolutions, Inc. Self-emulsifying compositions for drugs poorly soluble in water
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2004112723A2 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
JP2007513199A (ja) 2003-12-08 2007-05-24 ベントレー ファーマスーティカルス，インコーポレイテッド インスリン治療のための薬学的組成物及び方法
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (enrdf_load_html_response) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
ES511169A0 (es) 1983-10-01
NL8201413A (nl) 1982-11-01
GB2148711A (en) 1985-06-05
FR2502951B1 (fr) 1985-12-06
PT74703A (en) 1982-05-01
GB8408654D0 (en) 1984-05-16
GB2098865B (en) 1985-12-18
DK155882A (da) 1982-12-10
FI821123L (fi) 1982-10-07
SE8202172L (sv) 1982-10-07
GB2148711B (en) 1985-12-18
CA1192496A (en) 1985-08-27
NZ200232A (en) 1985-08-16
IL65424A0 (en) 1982-07-30
PT74703B (en) 1984-05-30
FR2502951A1 (fr) 1982-10-08
MY8600571A (en) 1986-12-31
IT8220611A0 (it) 1982-04-06
FI821123A7 (fi) 1982-10-07
DE3212053A1 (de) 1982-10-21
ES8308698A1 (es) 1983-10-01
FI821123A0 (fi) 1982-03-31
GB2098865A (en) 1982-12-01
AU564570B2 (en) 1987-08-20
AU8233482A (en) 1982-10-14

Similar Documents

Publication Publication Date Title
FR2501688B1 (enrdf_load_html_response)
FR2501649B1 (enrdf_load_html_response)
FR2497895B1 (enrdf_load_html_response)
GR75462B (enrdf_load_html_response)
FR2498929B1 (enrdf_load_html_response)
FR2502154B1 (enrdf_load_html_response)
CH655537B (enrdf_load_html_response)
CH656048B (enrdf_load_html_response)
FR2498105B1 (enrdf_load_html_response)
FR2499108B1 (enrdf_load_html_response)
FR2498372B1 (enrdf_load_html_response)
FR2498380B1 (enrdf_load_html_response)
FR2502074B1 (enrdf_load_html_response)
FR2499018B1 (enrdf_load_html_response)
FR2498392B1 (enrdf_load_html_response)
FR2499837B3 (enrdf_load_html_response)
FR2498317B1 (enrdf_load_html_response)
FR2498436B1 (enrdf_load_html_response)
FR2498206B1 (enrdf_load_html_response)
FR2498599B1 (enrdf_load_html_response)
FR2502682B1 (enrdf_load_html_response)
FR2502207B1 (enrdf_load_html_response)
FR2498969B1 (enrdf_load_html_response)
FR2498422B3 (enrdf_load_html_response)
FR2498744B3 (enrdf_load_html_response)